Metabolic and Signaling Pathways Affected by Photodynamic Therapy (PDT) with Protoporphyrin IX

Protoporphyrin IX (PpIX) occupies a unique nexus in photodynamic therapy (PDT) by bridging the endogenous metabolism of heme biosynthesis with highly efficient, light-induced cytotoxicity. Administered via its precursor 5-aminolevulinic acid (5-ALA) or its derivatives, intracellularly generated PpIX undergoes intersystem crossing upon irradiation to predominantly initiate Type II photochemistry. This process yields singlet oxygen and ancillary reactive oxygen species (ROS) characterized by a strict, nanometer-scale radius of molecular attack. Consequently, the spatiotemporal kinetics of PDT are dictated by the precise subcellular compartmentalization of PpIX within the mitochondria, mitochondrial-associated membranes (MAMs), endoplasmic reticulum, lysosomes, and plasma membrane. Beyond inducing direct biomolecular damage, PpIX-PDT operates as a localized selector of complex signaling networks, orchestrating organelle communication, redox-mediated pathways, and cell fate adaptations. This comprehensive review systematically delineates the metabolic parameters governing intracellular PpIX accumulation, the biophysical mechanisms driving its excitation, and the subsequent cascade from primary oxidative stress to downstream signaling responses. Crucially, we present a novel, integrated framework that seamlessly connects upstream transporter kinetics and metabolic flux directly to downstream immunogenic and therapeutic outcomes. Ultimately, these multifaceted properties establish 5-ALA-mediated PpIX-PDT as a powerful theranostic platform, advancing pathway-oriented and personalized strategies to optimize modern anticancer interventions.